Rat CYP24A1 acts on 20-hydroxyvitamin D3 producing hydroxylated products with increased biological activity

Elaine W. Tieu, Edith K Y Tang, Jianjun Chen, Wei Li, Minh N. Nguyen, Zorica Janjetovic, Andrzej Slominski, Robert C. Tuckey

Research output: Contribution to journalArticle

31 Citations (Scopus)

Abstract

20-Hydroxyvitamin D3 (20(OH)D3), the major product of CYP11A1 action on vitamin D3, is biologically active and is produced in vivo. As well as potentially having important physiological actions, it is of interest as a therapeutic agent due to its lack of calcemic activity. In the current study we have examined the ability of CYP24A1, the enzyme that inactivates 1,25-dihydroxyvitamin D3 (1,25(OH)2D 3), to metabolize 20(OH)D3. Rat CYP24A1 was expressed in Escherichia coli, purified by Ni-affinity chromatography and assayed with substrates incorporated into phospholipid vesicles which served as a model of the inner mitochondrial membrane. In this system CYP24A1 metabolized 1,25(OH)2D3 with a catalytic efficiency 1.4-fold higher than that seen for 25-hydroxyvitamin D3 (25(OH)D3). CYP24A1 hydroxylated 20(OH)D3 to several dihydroxy-derivatives with the major two identified by NMR as 20,24-dihydroxyvitamin D3 (20,24(OH)2D3) and 20,25-dihydroxyvitamin D3 (20,25(OH)2D3). The catalytic efficiency of CYP24A1 for 20(OH)D3 metabolism was more than 10-fold lower than for either 25(OH)D3 or 1,25(OH)2D3 and no secondary metabolites were produced. The two major products, 20,24(OH)2D 3 and 20,25(OH)2D3, caused significantly greater inhibition of colony formation by SKMEL-188 melanoma cells than either 1,25(OH)2D3 or the parent 20(OH)D3, showing that CYP24A1 plays an activating, rather than an inactivating role on 20(OH)D3.

Original languageEnglish (US)
Pages (from-to)1696-1704
Number of pages9
JournalBiochemical Pharmacology
Volume84
Issue number12
DOIs
StatePublished - Dec 15 2012

Fingerprint

Bioactivity
Rats
Cholesterol Side-Chain Cleavage Enzyme
Affinity chromatography
Calcifediol
Calcitriol
Cholecalciferol
Mitochondrial Membranes
Metabolites
Vitamin D3 24-Hydroxylase
20-hydroxyvitamin D3
Affinity Chromatography
Metabolism
Escherichia coli
Melanoma
Phospholipids
Nuclear magnetic resonance
Derivatives
Membranes
Substrates

All Science Journal Classification (ASJC) codes

  • Pharmacology
  • Biochemistry

Cite this

Rat CYP24A1 acts on 20-hydroxyvitamin D3 producing hydroxylated products with increased biological activity. / Tieu, Elaine W.; Tang, Edith K Y; Chen, Jianjun; Li, Wei; Nguyen, Minh N.; Janjetovic, Zorica; Slominski, Andrzej; Tuckey, Robert C.

In: Biochemical Pharmacology, Vol. 84, No. 12, 15.12.2012, p. 1696-1704.

Research output: Contribution to journalArticle

Tieu, EW, Tang, EKY, Chen, J, Li, W, Nguyen, MN, Janjetovic, Z, Slominski, A & Tuckey, RC 2012, 'Rat CYP24A1 acts on 20-hydroxyvitamin D3 producing hydroxylated products with increased biological activity', Biochemical Pharmacology, vol. 84, no. 12, pp. 1696-1704. https://doi.org/10.1016/j.bcp.2012.09.032
Tieu, Elaine W. ; Tang, Edith K Y ; Chen, Jianjun ; Li, Wei ; Nguyen, Minh N. ; Janjetovic, Zorica ; Slominski, Andrzej ; Tuckey, Robert C. / Rat CYP24A1 acts on 20-hydroxyvitamin D3 producing hydroxylated products with increased biological activity. In: Biochemical Pharmacology. 2012 ; Vol. 84, No. 12. pp. 1696-1704.
@article{6edbc71037bb4b4eab6a78bf7884f04d,
title = "Rat CYP24A1 acts on 20-hydroxyvitamin D3 producing hydroxylated products with increased biological activity",
abstract = "20-Hydroxyvitamin D3 (20(OH)D3), the major product of CYP11A1 action on vitamin D3, is biologically active and is produced in vivo. As well as potentially having important physiological actions, it is of interest as a therapeutic agent due to its lack of calcemic activity. In the current study we have examined the ability of CYP24A1, the enzyme that inactivates 1,25-dihydroxyvitamin D3 (1,25(OH)2D 3), to metabolize 20(OH)D3. Rat CYP24A1 was expressed in Escherichia coli, purified by Ni-affinity chromatography and assayed with substrates incorporated into phospholipid vesicles which served as a model of the inner mitochondrial membrane. In this system CYP24A1 metabolized 1,25(OH)2D3 with a catalytic efficiency 1.4-fold higher than that seen for 25-hydroxyvitamin D3 (25(OH)D3). CYP24A1 hydroxylated 20(OH)D3 to several dihydroxy-derivatives with the major two identified by NMR as 20,24-dihydroxyvitamin D3 (20,24(OH)2D3) and 20,25-dihydroxyvitamin D3 (20,25(OH)2D3). The catalytic efficiency of CYP24A1 for 20(OH)D3 metabolism was more than 10-fold lower than for either 25(OH)D3 or 1,25(OH)2D3 and no secondary metabolites were produced. The two major products, 20,24(OH)2D 3 and 20,25(OH)2D3, caused significantly greater inhibition of colony formation by SKMEL-188 melanoma cells than either 1,25(OH)2D3 or the parent 20(OH)D3, showing that CYP24A1 plays an activating, rather than an inactivating role on 20(OH)D3.",
author = "Tieu, {Elaine W.} and Tang, {Edith K Y} and Jianjun Chen and Wei Li and Nguyen, {Minh N.} and Zorica Janjetovic and Andrzej Slominski and Tuckey, {Robert C.}",
year = "2012",
month = "12",
day = "15",
doi = "10.1016/j.bcp.2012.09.032",
language = "English (US)",
volume = "84",
pages = "1696--1704",
journal = "Biochemical Pharmacology",
issn = "0006-2952",
publisher = "Elsevier Inc.",
number = "12",

}

TY - JOUR

T1 - Rat CYP24A1 acts on 20-hydroxyvitamin D3 producing hydroxylated products with increased biological activity

AU - Tieu, Elaine W.

AU - Tang, Edith K Y

AU - Chen, Jianjun

AU - Li, Wei

AU - Nguyen, Minh N.

AU - Janjetovic, Zorica

AU - Slominski, Andrzej

AU - Tuckey, Robert C.

PY - 2012/12/15

Y1 - 2012/12/15

N2 - 20-Hydroxyvitamin D3 (20(OH)D3), the major product of CYP11A1 action on vitamin D3, is biologically active and is produced in vivo. As well as potentially having important physiological actions, it is of interest as a therapeutic agent due to its lack of calcemic activity. In the current study we have examined the ability of CYP24A1, the enzyme that inactivates 1,25-dihydroxyvitamin D3 (1,25(OH)2D 3), to metabolize 20(OH)D3. Rat CYP24A1 was expressed in Escherichia coli, purified by Ni-affinity chromatography and assayed with substrates incorporated into phospholipid vesicles which served as a model of the inner mitochondrial membrane. In this system CYP24A1 metabolized 1,25(OH)2D3 with a catalytic efficiency 1.4-fold higher than that seen for 25-hydroxyvitamin D3 (25(OH)D3). CYP24A1 hydroxylated 20(OH)D3 to several dihydroxy-derivatives with the major two identified by NMR as 20,24-dihydroxyvitamin D3 (20,24(OH)2D3) and 20,25-dihydroxyvitamin D3 (20,25(OH)2D3). The catalytic efficiency of CYP24A1 for 20(OH)D3 metabolism was more than 10-fold lower than for either 25(OH)D3 or 1,25(OH)2D3 and no secondary metabolites were produced. The two major products, 20,24(OH)2D 3 and 20,25(OH)2D3, caused significantly greater inhibition of colony formation by SKMEL-188 melanoma cells than either 1,25(OH)2D3 or the parent 20(OH)D3, showing that CYP24A1 plays an activating, rather than an inactivating role on 20(OH)D3.

AB - 20-Hydroxyvitamin D3 (20(OH)D3), the major product of CYP11A1 action on vitamin D3, is biologically active and is produced in vivo. As well as potentially having important physiological actions, it is of interest as a therapeutic agent due to its lack of calcemic activity. In the current study we have examined the ability of CYP24A1, the enzyme that inactivates 1,25-dihydroxyvitamin D3 (1,25(OH)2D 3), to metabolize 20(OH)D3. Rat CYP24A1 was expressed in Escherichia coli, purified by Ni-affinity chromatography and assayed with substrates incorporated into phospholipid vesicles which served as a model of the inner mitochondrial membrane. In this system CYP24A1 metabolized 1,25(OH)2D3 with a catalytic efficiency 1.4-fold higher than that seen for 25-hydroxyvitamin D3 (25(OH)D3). CYP24A1 hydroxylated 20(OH)D3 to several dihydroxy-derivatives with the major two identified by NMR as 20,24-dihydroxyvitamin D3 (20,24(OH)2D3) and 20,25-dihydroxyvitamin D3 (20,25(OH)2D3). The catalytic efficiency of CYP24A1 for 20(OH)D3 metabolism was more than 10-fold lower than for either 25(OH)D3 or 1,25(OH)2D3 and no secondary metabolites were produced. The two major products, 20,24(OH)2D 3 and 20,25(OH)2D3, caused significantly greater inhibition of colony formation by SKMEL-188 melanoma cells than either 1,25(OH)2D3 or the parent 20(OH)D3, showing that CYP24A1 plays an activating, rather than an inactivating role on 20(OH)D3.

UR - http://www.scopus.com/inward/record.url?scp=84869225008&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84869225008&partnerID=8YFLogxK

U2 - 10.1016/j.bcp.2012.09.032

DO - 10.1016/j.bcp.2012.09.032

M3 - Article

C2 - 23041230

AN - SCOPUS:84869225008

VL - 84

SP - 1696

EP - 1704

JO - Biochemical Pharmacology

JF - Biochemical Pharmacology

SN - 0006-2952

IS - 12

ER -